Поисковый запрос: (<.>S=БЕНЗЕРАЗИД<.>) |
Общее количество найденных документов : 18
Показаны документы с 1 по 18
|
1.
| Sternic N. Open study of sustained - release formulation of levodopa and benserazide in Parkinsonian patients // New. Trends Clin. Neuropharmacol., 1989. Vol. 3, N 2.-С.38
|
2.
| Duterte-Boucher D. Subchronic modifications of dopaminergic transmissions induce sensitization to apmorphine-induced climbing in aspontaneously unresponsive DBA2 mice // Fundam. and Clin. Phormacol., 1989. Vol. 3, N 5.-С.554
|
3.
| Substitution to jevodopa standard formulation of Modopar-LP in 5 severely disabled Parkinsonians // Fund. and Clin. Pharmacol., 1989. Vol. 3, N 4.-С.466-467
|
4.
| Villares J.C.B. Sebum secretion in idiopathic Parkinson's disease: effect of anticholinergic and dopaminergic drugs // Acta neurol. scand, 1989. Vol. 80, N 1.-С.57-63
|
5.
| Reinhard John E.(Jr) Inhibition of tyrosine-3-monooxygenase by benserazide // Biochem. Pharmacol., 1990. Vol. 39, N 9.-С.1489-1491
|
6.
| Central action of benserazide after COMT inhibition demonstrated in vivo by PET // J. Neural Transmiss., 1991. Vol. 85, N 1.-С.11-17
|
7.
| Apomorphine in malignant syndrome due to levodopa withdrawal // Ital. J. Neurol. Sci., 1992. Vol. 13, N 2.-С.169-170
|
8.
| Erisir Оценка клинического состояния с помощью шкалы Вебстера у больных идиопатическим паркинсонизмом, получавших L-ДОФА + бензеразид // Haseki tip bul., 1990. Vol. 28, N 2.-С.105-111
|
9.
| Johansen Patricia A. Inhibition of tryptophan hydroxylase by benserazide and other catechols // Biochem. Pharmacol., 1991. Vol. 41, N 4.-С.625-628
|
10.
| Soares-da-Silva Uptake of L-3,4-dihydroxyphenylalanine and dopamine formation in cultured renal epithelial cells // Biochem. Pharmacol., 1997. Vol. 54, N 9.-С.1037-1046
|
11.
| Определение высокоскоростной жидкостной хроматографией (HPIC) леводопы в плазме испытуемого при исследовании фармакокинетики дисперсионных таблеток леводопы/бензеразида // Zhongguo xinyao zazhi, 2001. Vol. 10, N 1-12.-С.110-112
|
12.
| Behandlung des idiopathischen und uramischen Restless-legs-Syndrom mit L-Dopa-Eine doppelblinde Cross-over-studie // Wien. med. Wochenschr., 1995. Vol. 145, N 17-18.-С.525-527
|
13.
| Jones A.L. The features and management of poisoning with drugs used to treat Parkinson's disease // Quart. J. Med., 1997. Vol. 90, N 10.-С.613-616
|
14.
| Gas chromatography/mass spectrometric identification of dopaminergic metabolites in striata of rats treated with L-DOPA // Rapid Commun. Mass. Spectrom., 2004. Vol. 18, N 5.-С.571-576
|
15.
| Ahlenius Evidence for the involvement of central 5-HT[1] receptors in the mediation of lordosis behavior in the female rat // Psychopharmacology, 1989. Vol. 98, N 4.-С.440-444
|
16.
| Effect of L-dopa on dementiarelated rigidity // Acta neurol. scand., 1989. Vol. 80, N 1.-С.64-67
|
17.
| Thomson Development of an assay for levodopa, benserazide and carbidopa using HPLC with electrochemical detection // J. Pharm. and Pharmacol., 1988. Vol. 40, Suppl..-С.112
|
18.
| Treatment of idiopathic parkinsonism with L-dopa in the absence and presence of decarboxylase inhibitors: effects on plasma levels of L-dopa, dopa decarboxylase, catecholamines and 3-О-methyl-dopa // J. Neurol., 1989. Vol. 236, N 4.-С.223-230
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"